Kathryn L. Hassell M.D.

Associate Professor of Medicine

Go To Full Curriculum Vitae

Medical School:
University of Minnesota Medical School, Minneapolis, Minnesota
Postgraduate training:
1986-1989 Intern and Resident in Internal Medicine, North Carolina Memorial Hospital,
University of North Carolina, Chapel Hill, North Carolina
1989-1992 Fellow in Hematology/Oncology, University of Colorado Denver, Denver, Colorado
When arrived at UCD:
1989
Past and current professional positions:
1991-2002 Associate Director, Colorado Sickle Cell Treatment and Research Center, Denver, Colorado
1992-1993 Instructor in Medicine, Division of Hematology, University of Colorado Denver, Denver, Colorado
1993-1999 Assistant Professor of Medicine, University of Colorado Denver, Denver, Colorado
1999-present Associate Professor of Medicine, University of Colorado Denver, Denver, Colorado
2002-present Interim Director, Colorado Sickle Cell Treatment and Research Center, Denver, Colorado
Memberships and other information:
Council on Thrombosis
American Heart Association
American Society of Hematology
International Society of Thrombosis & Haemostasis
American Society of Clinical Pathologists
Board Certification:
Internal Medicine - 1989
Medical Oncology - 1991, 2001
Hematology - 1992, 2002
Awards received:
1986 Alpha Omega Alpha
Major Scientific Interest:
Coagulation disorders including antiphospholipid antibody syndrome and heparin-induced thrombocytopenia, investigation of novel anticoagulant therapies and strategies, hemoglobinopathies/sickle cell disease including mechanisms of vascular injury and chronic organ damage
Major Clinical Interest:
Coagulation disorders and anticoagulation management, hemoglobinopathies including sickle cell disease, hematology support of the Bloodless Surgery Program
Representative Publications:
  1. K.L. Hassell and R. Marlar. Acquired protein S deficiency in HIV infected individuals. Clin Hemostasis Rev 6:14, 1992.
  2. K.L. Hassell, P.A. Lane and J.R. Eckman. Acute multiorgan failure syndrome: A potentially catastrophic complication of severe sickle cell pain episodes. Am J Med 96:155-162, 1994.
  3. G.R. Buchanan, D.W. Luckey, D.L. Wethers, K.L. Hassell, G.M. Woods, Z.R. Rogers, J.L. Lear, J.L. O’Connell and P.A. Lane. Functional asplenia in hemoglobin SC disease. Blood 85:2238-2244, 1995.
  4. B.L. Steel, K.L. Hassell, C. Rajagopalan, T. Parsons, T. Braun, and R.A. Marlar. Unique case of brothers with moderate Factor XI deficiency and one with severe bleeding after surgery. Clin Appl Thromb Hemostasis 2:14-17, 1996.
  5. KL Hassell. Hypercoagulable states in deep venous thrombosis. Primary Care Case Rev 1(2), 1998.
  6. K.L. Hassell. Altered hemostasis in pulmonary hypertension. Blood coagul fibrinolysis 9:107-117, 1998.
  7. K.L. Hassell. Anticoagulation in Heparin-Induced Thrombocytopenia: An Ongoing Challenge. Hospital Physician 36:56-61, 2000
  8. L. Barbour and K Hassell. Prevention of Deep Vein Thrombosis and Pulmonary Embolism. ACOG Pract Bull 21, October 2000.
univeristy of colorado health sciences center department of medicine at u c h s c school of medicine at u c h s c division of infectious diseases home